Organon Korea
We are a global healthcare company with a portfolio of therapies and products in womens health, biosimilars, and established brands across a wide array of conditions and diseases.
Our portfolio encompasses more than 60 medicines and products across a range of areas including reproductive health, heart disease, oncology, immunology, dermatology, allergy, and asthma. We bring these important therapies to more than 140 markets around the world.
Our portfolio encompasses more than 60 medicines and products across a range of areas including reproductive health, heart disease, oncology, immunology, dermatology, allergy, and asthma. We bring these important therapies to more than 140 markets around the world.
Exhibition Item
AtozetSatellite Symposium
Lunchtime Activities
Latest Trends in Dyslipidemia Management for Very High-risk ASCVD Patients
Organized by CVRF and Supported by Educational Grant from Organon Korea
Friday, April 26
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Presentation Room 2, Level 1
Moderator(s): Youngkeun Ahn, Chang-Wook Nam
12:45 PM | Recent Trends and Clinical Evidence for Optimizing Lipid Management : A Focus on Ezetimibe Combination Therapy Lecturer: Ju Yeol Baek |
1:05 PM | High-dose Atorvastatin and Ezetimibe Combination for Treatment of Dyslipidemia Patients with ASCVD Lecturer: Gyu-Chul Oh |
1:25 PM | Discussion |
Lunchtime Activities
Lower for Longer: Reframing the Clinical Goal for LDL-C
Organized by CVRF and Supported by Educational Grant from Organon Korea
Saturday, April 27
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Presentation Room 1, Level 1
Moderator(s): Young-Guk Ko, Bon-Kwon Koo
Panelist(s): Young Rak Cho, Sung Uk Kwon, Bong Ryeol Lee, Kyounghoon Lee, Kyung-Taek Park, Ji-Wung Ryu
12:45 PM | What are the Real-world Issue to Keep LDL-C Lower for Longer Lecturer: Seok-Jae Hwang |
1:05 PM | How Do We Achieve Lower for Longer LDL-C Levels for Patients Lecturer: Sang Don Park |
1:25 PM | Discussion |